ABBV AbbVie
$246.04 +0.89%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.89%
YTD
+24.20%
P/E
118.55
P/B
94.44
ROE
95.6%
Div yield
2.8%
Beta
-0.07
Market cap
$430.9B
RSI (14)
42
Next earnings
Oct 29, 2026
Previous session
close of Aug 7, 2026 · EOD, no live order bookOpen
$243.62
Close
$246.04
VWAP (n/a)
—
Day high
$246.76
Day low
$241.99
Volume
4.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance · Aug 7
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed
Yahoo Finance · Aug 7
The Two Divergent Paths Priced Into Eli Lilly Stock
Yahoo Finance · Aug 7
Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
Yahoo Finance · Aug 7
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
Yahoo Finance · Aug 7
REGENXBIO Q2 Earnings Call Highlights
Yahoo Finance · Aug 7
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 5, 2026 View → 10-Q Aug 3, 2026 View → 8-K Jul 31, 2026 View → 8-K Jul 6, 2026 View → 8-K Jun 22, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ABBV. Try it in the Lab to size a position and see the risk.